Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04309539
Other study ID # MFM-IRB, MD.20.02.280
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 21, 2020
Est. completion date March 2022

Study information

Verified date September 2020
Source Mansoura University
Contact Mona A Hasheesh, MD
Phone 00201027034020
Email drmonahasheesh@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This patient population is typically elderly and frail. They are at risk of adverse effects secondary to inadequate pain management such as prolonged admissions and poor functional outcomes.

Regional analgesia is preferred due to their opioid-sparing effects and reduction in related adverse effects but The analgesia from these blocks is only moderate and literature suggests that the obturator nerve (ON) is not covered.


Description:

The aim of this study is to compare the effect of combined lateral femoral cutaneous nerve block with pericapsular nerve group block versus fascia iliaca block for proximal femur surgery.

Fascia iliaca compartment block is a simple technique to manage pain before positioning for spinal anesthesia performance and it constitutes a practical choice for perioperative pain control.

A recent anatomical study confirmed the innervation of the anterior hip by these 3 main nerves, but also found that the AON and FN play a greater role in the anterior hip innervation than previously reported The high articular branches from FN and AON are consistently found between the anterior inferior iliac spine (AIIS) and the iliopubic eminence (IPE), whereas the ON is located close to the inferomedial acetabulum.

The ultrasound-guided technique for blockade of these articular branches to the hip, the PENG (Pericapsular Nerve Group) block reported significantly reduced pain scores compared with baseline. Roy et al 2019 recommended the use of PENG block together with LFCN block as adjunctive to cover the lateral surgical incision.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date March 2022
Est. primary completion date June 2021
Accepts healthy volunteers No
Gender All
Age group 50 Years to 90 Years
Eligibility Inclusion Criteria:

- American Society of Anesthesiologists (ASA) physical status I, II and III.

Exclusion Criteria:

- Patient refusal.

- Neuromuscular diseases

- Hematological diseases

- Bleeding abnormality

- Coagulation abnormality.

- Psychiatric diseases.

- Local skin infection at the site of the block.

- Local skin sepsis at the site of the block

- Known intolerance to the study drugs.

- Body Mass Index > 40 Kg/m2.

- Multiple trauma patients.

Study Design


Intervention

Procedure:
Fascia iliaca block
A linear probe will be placed in the sagittal plane to the inguinal ligament to obtain an image of "bow-tie sign" formed by the muscle fascias, a spinal needle will be inserted 1 cm cephalad Using an in-plane approach, the fascia iliaca is penetrated, 30 mL of bupivacaine 0.25% before spinal anesthesia.
combined LFCN block with PENG block
With the patient supine, the linear probe is placed parallel to the inguinal ligament. LFCN appear as a hypoechoic oval structure between the tensor fascia lata and Sartorius muscles. The needle is inserted in plane. 5 mL of LA is injected. The PENG block will be performed in the supine position. A curvilinear probe will be placed transversely over the anterior inferior iliac spine and then rotated counterclockwise 45 degrees. the ilio pubic eminence, the iliopsoas muscle and tendon, the femoral artery, and pectineus muscle will be observed. A spinal needle will be inserted in plane to the plane between the psoas tendon and the pubic ramus. 25 mL of bupivacaine 0.25% will be injected

Locations

Country Name City State
Egypt Mansoura University, emergency hospital Mansourah DK

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time of performance of Spinal Anesthesia Is defined as the time measured from the start of positioning to the completion of the intrathecal bupivacaine injection just before surgery.
Secondary Pain measurement at rest 10-cm visual analog scale (VAS) for pain, where 0 is equal to no pain and 10 indicates the worst possible pain immediately and 1 hour at PACU, then in the surgical ward at 2,4,6,8,12,18 and 24 h after surgery.
Secondary Pain measurement on movement (attempted hip flexion to 15 degrees).: 10-cm visual analog scale (VAS) for pain, where 0 is equal to no pain and 10 indicates the worst possible pain immediately and 1 hour at PACU, then in the surgical ward at 2,4,6,8,12,18 and 24 h after surgery.
Secondary Pain measurement during positioning for spinal anesthesia visual analog scale (0-10, 0: no pain, 10: worst pain imaginable) during changing position from supine to sitting one Just before surgery
Secondary The severity of postoperative pain at rest 10-cm visual analog scale (VAS) for pain, where 0 is equal to no pain and 10 indicates the worst possible pain immediately and 1 hour at PACU, then in the surgical ward at 2,4,6,8,12,18 and 24 h after surgery.
Secondary The severity of postoperative pain on movement (attempted hip flexion to 15 degrees): 10-cm visual analog scale (VAS) for pain, where 0 is equal to no pain and 10 indicates the worst possible pain immediately and 1 hour at PACU, then in the surgical ward at 2,4,6,8,12,18 and 24 h after surgery.
Secondary Time to onset of Sensory blockade cold perception loss in the lateral, anterior and medial part of the thigh (corresponding to lateral femoral cutaneous (LFC), femoral (F) and obturator (O)nerve sensory distributions, respectively) evaluated 15 and 30 min after block administration
Secondary Time to onset of motor block defined as assessment of quadriceps femoris muscle strength by straight leg raise test to 15 degree and classified as follow: +ve =normal power, -ve =motor weakness evaluated 15 and 30 min after block administration
Secondary Duration of sensory block blockade is defined as the interval between end of injection and complete end of sensory block (score=2) postoperative 24 hours
Secondary Duration of motor block blockade is defined as the interval between end of injection and complete end of injection and complete recovery of normal motor function (score=0), postoperative 24 hours
Secondary Anesthesiology satisfaction for patient positioning evaluated as 0=unsatisfactory, 1=satisfactory, 2=good or 3=optimal just before surgery
Secondary heart rate Changes in heart rate pre-block, 15, 30 min after block, immediately after spinal anesthesia, 5min, 15min then every 30 min till end of surgery
Secondary Mean arterial blood pressure Changes in Mean arterial blood pressure pre-block, 15, 30 min after block, immediately after spinal anesthesia, 5min, 15min then every 30 min till end of surgery
Secondary Peripheral oxygen saturation Changes in peripheral oxygen saturation as measured with pulse oximetry pre-block, 15, 30 min after block, immediately after spinal anesthesia, 5min, 15min then every 30 min till end of surgery
Secondary Time for first analgesic request defined as the time period from end of injection to the first time patient requests analgesia postoperatively Within 24 hours after surgery
Secondary Total analgesics received cumulative consumption of opioids during the first postoperative day for 24 hrs after surgery
Secondary Pruritis number of patients with pruritis Within 24 hours after surgery
Secondary nausea number of patients with nausea Within 24 hours after surgery
Secondary vomiting number of patients with vomiting Within 24 hours after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05920642 - Postoperative Pain Relieve for Patients Undergoing Surgical Treatment of Femoral Fracture Phase 4
Completed NCT01435538 - European Quality of Care Pathways Study on the Effect of Care Pathways on Interprofessional Teamwork (EQCP-TEAM) N/A
Not yet recruiting NCT06396884 - Hemodynamic Optimization During Spinal Anesthesia in the Elderly
Terminated NCT01035177 - In Vivo Hip Fracture Discrimination With Quantitative Computed Tomography (QCT) N/A
Completed NCT05091359 - Femur Transtrochanteric Fractures Treated With Dynamic Hip Screw and Calcium Sulfate Scaffold. N/A
Not yet recruiting NCT01235169 - Evaluation of the Proximal Femoral Nail Antirotation With Cement Augmentation in Osteoporotic Femoral Neck Fractures Phase 1/Phase 2